title: [Myocardial scintigraphy using omega-I-123 heptadecanoic acid (Rossendorf) in patients with coronary disease].
abstract: Scintigraphy using labelled myocardial metabolism precursors makes possible a noninvasive qualitative--and increasingly also quantitative--evaluation of global and regional myocardium, both normally and insufficiently perfused, with normal and disturbed metabolism. Among the labelled precursors, free fatty acids appear as most important, especially the omega-123I-heptadecanoic acid. The experience with the use of this myocardial metabolism precursor in 23 examinations of 11 patients is described.
authors: I. Medizinische Klinik, Städtisches Krankenhaus im Friedrichshain, Berlin.
authors: E
authors: E
authors: Lohr
authors: T
authors: T
authors: Mende
authors: J
authors: J
authors: Steinbach
authors: R
authors: R
authors: Hliscs
authors: G
authors: G
authors: Anders
authors: W G
authors: WG
authors: Franke
authors: G J
authors: GJ
authors: Beyer
mesh_terms: D003327:Coronary Disease / Q000000981:diagnostic imaging*; D005227:Fatty Acids; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D007457:Iodine Radioisotopes; D011877:Radionuclide Imaging
chemical_list: D005227:Fatty Acids; D007457:Iodine Radioisotopes; C013102:margaric acid
vernacular_title: Die Myokardszintigraphie mit Omega-123I-Heptadekansäure (Rossendorf) bei Patienten mit koronarer Herzkrankheit.